Overcoming platinum drug resistance with copper-lowering agents

Anticancer Research

Volumn 33, Issue 10, 2013, Pages 4157-4162

  Chen, Helen H W ^a   Kuo, Macus Tien ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cisplatin; Copper chelator; High affinity human copper transporter 1 (hCtr1); Review

Indexed keywords

ANTINEOPLASTIC AGENT; CARRIER PROTEINS AND BINDING PROTEINS; CISPLATIN; COPPER; COPPER LOWERING AGENT; HUMAN COPPER TRANSPORTER 1; PLATINUM; UNCLASSIFIED DRUG;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL STRESS; DRUG RESISTANCE; DRUG TRANSPORT; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

CISPLATIN; COPPER CHELATOR; HIGH-AFFINITY HUMAN COPPER TRANSPORTER 1 (HCTR1); REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CATION TRANSPORT PROTEINS; CHELATING AGENTS; CISPLATIN; CLINICAL TRIALS AS TOPIC; COPPER; DRUG RESISTANCE, NEOPLASM; HUMANS; STRESS, PHYSIOLOGICAL;

EID: 84891351357     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Muggia F: Platinum compounds 30 years after the introduction of cisplatin: implications for the treatment of ovarian cancer. Gynecol Oncol 112: 275-281, 2009.
2. Wang D and Lippard SJ: Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4: 307-320, 2005.
3. Kim ES, Lee JJ, He G, Chow CW, Fujimoto J, Kalhor N, Swisher SG, Wistuba II, Stewart DJ and Siddick ZH: Tissue platinum concentration and tumor response in non-small-cell lung cancer. J Clin Oncol 30: 3345-3352, 2012.
4. Howell SB, Safaei R, Larson CA and Sailor MJ: Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs. Mol Pharmacol 77: 887-894, 2010.
5. Kuo MT, Fu S, Savaraj N and Chen HH: Role of the human high-affinity copper transporter in copper homeostasis regulation and cisplatin sensitivity in cancer chemotherapy. Cancer Res 72: 4616-4621, 2012.
6. Kuo MT, Chen HH, Song IS, Savaraj N and Ishikawa T: The roles of copper transporters in cisplatin resistance. Cancer Metastasis Rev 26: 71-83, 2007.
7. Ishida S, Lee J, Thiele DJ and Herskowitz I: Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc Natl Acad Sci USA 99: 14298-14302, 2002.
8. Holzer AK, Manorek GH and Howell SB: Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin. Mol Pharmacol 70: 1390-1394, 2006.
9. Liang ZD, Stockton D, Savaraj N and Kuo MT: Mechanistic comparison of human high-affinity copper transporter 1-mediated transport between copper ion and cisplatin. Mol Pharmacol 76: 843-853, 2009.
10. Liang ZD, Long Y, Tsai WB, Fu S, Kurzrock R, Gagea-Iurascu M, Zhang F, Chen HH, Hennessy BT, Mills GB, Savaraj N and Kuo MT: Mechanistic basis for overcoming platinum resistance using copper chelating agents. Mol Cancer Ther 11: 2483-2494, 2012.
11. De Feo CJ, Aller SG, Siluvai GS, Blackburn NJ and Unger VM: Three-dimensional structure of the human copper transporter hCTR1. Proc Natl Acad Sci USA 106: 4237-4342, 2009.
12. Hassett R and Kosman DJ: Evidence for Cu(II) reduction as a component of copper uptake by Saccharomyces cerevisiae . J Biol Chem 270: 128-134,1995.
13. Sze CM, Khairallah GN, Xiao Z, Donnelly PS, O'Hair RA and Wedd AG: Interaction of cisplatin and analogues with a Met-rich protein site. J Biol Inorg Chem 14: 163-165, 2009.
14. Crider SE, Holbrook RJ and Franz KJ: Coordination of platinum therapeutic agents to met-rich motifs of human copper transport protein1. Metallomics 2: 74-83, 2010.
15. Wu Z, Liu Q, Liang X, Yang X, Wang N, Wang X, Sun H, Lu Y and Guo Z: Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1. J Biol Inorg Chem 14: 1313-1323, 2009.
16. Wang X, Du X, Li H, Chan DS and Sun H: The effect of the extracellular domain of human copper transporter (hCTR1) on cisplatin activation. Angew Chem Int Ed Engl 50: 2706-2711, 2011.
17. Long F, Su CC, Zimmermann MT, Boyken SE, Rajashankar KR, Jernigan RL and Yu EW: Crystal structures of the CusA efflux pump suggest methionine-mediated metal transport. Nature 467: 484-488, 2010.
18. Kuo MT, Liu Z, Wei Y, Lin-Lee YC, Tatebe S, Mills GB and Unate H: Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-kappaB signaling. Oncogene 21: 1945-1954, 2002.
19. Rutherford JC and Bird AJ: Metal-responsive transcription factors that regulate iron, zinc, and copper homeostasis in eukaryotic cells. Eukaryot Cell 3: 1-13, 2004.
20. Jensen LT, Posewitz MC, Srinivasan C and Winge DR: Mapping of the DNA binding domain of the copper-responsive transcription factor Mac1 from Saccharomyces cerevisiae. J Biol Chem 273: 23805-23811, 1998.
21. Labbe S, Zhu Z and Thiele DJ: Copper-specific transcriptional repression of yeast genes encoding critical components in the copper transport pathway. J Biol Chem 272: 15951-15958, 1997.
22. Selvaraj A, Balamurugan K, Yepiskoposyan H, Zhou H, Egli D, Georgiev O, Thiele DJ, and Schaffner W: Metal-responsive transcription factor (MTF-1) handles both extremes, copper load and copper starvation, by activating different genes. Genes Dev 19: 891-896, 2005.
23. Penarrubia L, Andres-Colas N, Moreno J and Puig S: Regulation of copper transport in Arabidopsis thaliana: a biochemical oscillator? J Biol Inorg Chem 15: 29-36. 2010.
24. Yamasaki H, Hayashi M, Fukazawa M, Kobayashi Y and Shikanai T: SQUAMOSA Promoter Binding Protein-Like7 Is a Central Regulator for Copper Homeostasis in Arabidopsis. Plant Cell 21: 347-361, 2009.
25. Liang ZD, Tsai WB, Lee MY, Savaraj N and Kuo MT: Specificity protein 1 (sp1) oscillation is involved in copper homeostasis maintenance by regulating human high-affinity copper transporter 1 expression. Mol Pharmacol 81: 455-464, 2012.
26. Gill G, Pascal E, Tseng ZH and Tjian R: A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation. Proc Natl Acad Sci USA 91: 192-196, 1994.
27. Liu WL, Coleman RA, Ma E, Grob P, Yang JL, Zhang Y, Daily G, Nogales E and Tjian R: Structures of three distinct activator-TFIID complexes. Genes Dev 23: 1510-1521, 2009.
28. Pascal E and Tjian R: Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. Genes Dev 5: 1646-1656, 1991.
29. Guo Y, Smith K, Lee J, Thiele DJ and Petris MJ: Identification of methionine-rich clusters that regulate copper-stimulated endocytosis of the human Ctr1 copper transporter. J Biol Chem 279: 17428-17433, 2004.
30. Molloy SA and Kaplan JH: Copper-dependent recycling of hCTR1, the human high affinity copper transporter. J Biol Chem 284: 29704-29713, 2009.
31. Holzer AK and Howell SB: The internalization and degradation of human copper transporter 1 following cisplatin exposure. Cancer Res 66: 10944-10952, 2006.
32. Fu S, Naing A, Fu C, Kuo MT and Kurzrock R: Overcoming platinum resistance through the use of a copper-lowering agent. Mol Cancer Ther 11: 1221-1225, 2012.
33. Page MD, Kropat J, Hamel PP and Merchant SS: Two Chlamydomonas CTR copper transporters with a novel cys-met motif are localized to the plasma membrane and function in copper assimilation. Plant Cell 21: 928-943, 2009.